TCM
KLRS

Tang Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Tang Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$963K Buy
360,859
+51,638
+17% +$138K 0.05% 155
2025
Q1 		$2.48M Buy
309,221
+285,210
+1,188% +$2.29M 0.14% 103
2024
Q4 		$232K Buy
+24,011
New +$232K 0.02% 179